Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Schrodinger Inc (NQ: SDGR ) 18.75 -0.03 (-0.16%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Schrodinger Inc < Previous 1 2 3 4 5 Next > Schrödinger to Present at Jefferies London Healthcare Conference November 04, 2024 From Schrödinger Via Business Wire Schrödinger to Announce Third Quarter 2024 Financial Results on November 12 October 31, 2024 From Schrödinger Via Business Wire Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium October 23, 2024 From Schrödinger Via Business Wire Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) October 17, 2024 From Schrödinger Via Business Wire Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium October 09, 2024 From Schrödinger Via Business Wire Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) September 18, 2024 From Schrödinger Via Business Wire Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) August 16, 2024 From Schrödinger Via Business Wire Schrödinger to Present at Morgan Stanley Global Healthcare Conference August 14, 2024 From Schrödinger Via Business Wire Schrödinger Reports Strong Second Quarter 2024 Financial Results July 31, 2024 From Schrödinger Via Business Wire Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology July 26, 2024 From Schrödinger Via Business Wire Schrödinger to Announce Second Quarter 2024 Financial Results on July 31 July 17, 2024 From Schrödinger Via Business Wire Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) July 16, 2024 From Schrödinger Via Business Wire Simulations Plus Stock Drops 15% Despite EPS Beat July 05, 2024 Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) June 14, 2024 From Schrödinger Via Business Wire Schrödinger to Present at Jefferies Global Healthcare Conference May 22, 2024 From Schrödinger Via Business Wire Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) May 17, 2024 From Schrödinger Via Business Wire Schrödinger Reports First Quarter 2024 Financial Results May 01, 2024 From Schrödinger Via Business Wire Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) April 18, 2024 From Schrödinger Via Business Wire Schrödinger to Announce First Quarter 2024 Financial Results on May 1 April 10, 2024 From Schrödinger Via Business Wire Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting March 20, 2024 From Schrödinger Via Business Wire Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) March 19, 2024 From Schrödinger Via Business Wire Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results February 28, 2024 From Schrödinger Via Business Wire Schrödinger to Participate in Upcoming Investor Conferences February 20, 2024 From Schrödinger Via Business Wire Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) February 16, 2024 From Schrödinger Via Business Wire Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28 February 14, 2024 From Schrödinger Via Business Wire Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) January 19, 2024 From Schrödinger Via Business Wire Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals January 08, 2024 From Schrödinger Via Business Wire Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) December 19, 2023 From Schrödinger Via Business Wire Schrödinger Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event December 14, 2023 From Schrödinger Via Business Wire Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting December 10, 2023 From Schrödinger Via Business Wire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
